Pavel Petukhov, PhD
Medicinal Chemistry and Pharmacognosy
College of Pharmacy
Cancer Research/Clinical Interest
Discovery of isoform-selective histone deacetylase (HDAC) inhibitors. Development of photolabeling HDAC probes to determine the composition of the binding poses of the HDAC ligands, an essential step in the design of HDAC isoform-selective inhibitors.
Office: University of Illinois at Chicago
833 S. Wood St, Room 539, MC 781
Chicago, IL 60612